Comparative analysis of MS outcomes in natalizumab treated patients using a novel three way multinomial propensity score match

---

Spelman T., Pellegrini F., Zhang A., Trojano M., Wiendl H., Kappos L., ...Daha Fazla

32nd The European Committee for Treatment and Research in Multiple Sclerosis(ECTRIMS), 14 - 17 Eylül 2016

• Yayın Türü: Bildiri
• Ondokuz Mayıs Üniversitesi Adresli: Evet